Chapter 1: Introduction (Basic Principles) Flashcards

1
Q

the study of substances that interact with living systems through chemical processes, especially by binding to regulatory molecules and activating or inhibiting normal body processes.

A

Pharmacology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

defined as the science of substances used to prevent, diagnose, and treat disease

A

medical pharmacology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

the branch of pharmacology that deals with the undesirable effects of chemicals on living systems, from individual cells to humans to complex ecosystems

A

Toxicology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

is the study of the genetic variations that cause differences in drug response among individuals or populations. Future clinicians may screen every patient for a variety of such differences before prescribing a drug.

A

Pharmacogenomics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

These are of three major types of bond

A

covalent, electrostatic, and hydrophobic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

an inactive precursor chemical that is readily absorbed and distrib- uted must be administered and then converted to the active drug by biologic processes—inside the body

A

prodrug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

common type of permeation

A

Passive diffu- sion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

determines how readily the drug molecule moves between aqueous and lipid media

A

aqueous partition coefficient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

are selective, saturable, and inhibitable (type of transport)

A

active transport or facilitated diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

pro- cess by which the substance is bound at a cell-surface receptor, engulfed by the cell membrane, and carried into the cell by pinching off of the newly formed vesicle inside the membrane.

A
  1. Endocytosis and exocytosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

This process is responsible for the trans- port of vitamin B12, complexed with a binding protein (intrinsic factor) across the wall of the gut into the blood

A
  1. Endocytosis and exocytosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

iron is transported into hemoglobin-synthesizing red blood cell precursors in association with the protein transferrin

A
  1. Endocytosis and exocytosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

many neurotransmit- ter substances are stored in membrane-bound vesicles in nerve endings to protect them from metabolic destruction in the cyto- plasm ( what process of transport)

A

exocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

the science of drug preparation and the medical use of drugs—began to develop as the precursor to pharmacology.

A

materia medica

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hindu 760 medicinal herbs

A

susruta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

study of effects of drug on population

A

pharmacoepidemiology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

study of drug cost effectiveness

A

pharmacoeconomics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
  1. The primary consideration in all clinical trials is to
    (A) Determine the safety of the drug
    (B) Determine the efficacy of the drug
    (C)Ensure that there is no risk to the subject
    (D) Provide for the welfare of the subject
A
  1. D. There is always some degree of risk in clinical trials; the object is to minimize the risk to the pa- tient. The primary consideration in any clinical trial is the welfare of the subject. The safety of the drug is one objective for certain clinical trials as is the ef- ficacy of the drug in other trials.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  1. The history of pharmacology includes a long list of
    heroes. The person considered to be the founder of American pharmacology is
    (A) Claude Bernard
    (B) Rudolph Bucheim
    (C) John Jacob Abel
    (D) Oswald Schmeideberg
A

C. John Jacob Abel occupied the first chair of a de- partment of pharmacology in the United States. This was at the University of Michigan. Abel subse- quently left Michigan to chair the first department of pharmacology at Johns Hopkins University. Claude Bernard was an early French physiologist and pharmacologist. Rudolph Bucheim established one of the first pharmacology laboratories at the University of Dorpat (Estonia). Oswald Schmiedeberg is considered the founder of pharma- cology. He trained approximately 120 pupils from around the world, including the father of American pharmacology, John Jacob Abel.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

was written about 2700 B.C. and contained classifications of individual me- dicinal plants as well as compilations of plant mixtures to be used for medical purposes

A

Pen Tsao

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

contains about 800 prescriptions quite similar to those written today in that they have one or more active substances as well as vehicles (animal fat for ointments; and water, milk, wine, beer, or honey for liquids) for suspending or dissolving the active drug

A

Ebers papyrus (1550 B.C.),

22
Q

the science of preparing, com- pounding, and dispensing medicines

A

pharmacy

23
Q

the identification and preparation of crude drugs from natural sources).

A

pharmacognosy

24
Q

founder of modern pharmacology

A

Oswald Schmeideberg

25
Q

Offers maximal convenience; absorption is often slower. Subject to the first-pass effect, in which a significant amount of the agent is metabolized in the gut wall, portal circulation, and liver before it reaches the systemic circulation

A

Oral (swallowed)

26
Q

Direct absorption into the systemic venous circulation, bypassing the hepatic portal circuit and first-pass metabolism

A

Buccal and sublingual

27
Q

Instantaneous and complete absorption (by definition, bioavailability is 100%). Potentially more dangerous

A

Intravenous

28
Q

Often faster and more complete (higher bioavailability) than with oral administration. Large volumes may be given if the drug is not too irritating. First-pass metabolism is avoided.

A

Intramuscular

29
Q

Slower absorption than the intramuscular route. First-pass metabolism is avoided.

A

Subcutaneous

30
Q

The rectal route offers partial avoidance of the first-pass effect. Larger amounts of drug and drugs with unpleasant tastes ate better administered rectally than by the buccal or sublingual routes

A

Rectal (suppository)

31
Q

Route offers delivery closest to respiratory tissues (eg, for asthma). Usually very rapid absorption (eg, for anesthetic gases)

A

Inhalation

32
Q

The topical route includes application to the skin or to the mucous membrane of the eye, ear, nose, throat, airway, or vagina for local effect

A

Topical

33
Q

The transdermal route involves application to the skin for systemic effect. Absorption usually occurs very slowly (because of the thickness of the skin), but the first-pass effect is avoided

A

Transdermal

34
Q

Substances that act on biologic systems at the chemical (molecular) level and alter their functions

A

Drugs

35
Q

The molecular components of the body with which drugs interact to bring about their effects

A

Drug receptors

36
Q

The phase of drug movement from the site of administration into the tissues.

A

Distribution Phase

37
Q

The phase of drug inactivation or removal from the body by metabolism or excretion

A

Elimination Phase

38
Q

Absorption of material across a cell membrane by enclosing it in cell membrane material and pulling it into the cell, where it can be released.

A

Endocytosis:

39
Q

Movement of a molecule (eg,drug) through the biologic medium

A

Permeation

40
Q

expulsion of material from vesicles in the cell into the extracellular space

A

Exocytosis:

41
Q

The action of a drug on the body, including receptor interactions, dose-response phenomena, and mechanisms of therapeutic and toxic actions

A

Pharmacodynamics.

42
Q

The actions of the body on the drug, including absorption, distribution, metabolism, and elimination. Elimination of a drug may be achieved by metabolism or by excretion. Biodisposition is a term sometimes used to describe the processes of metabolism and excretion

A

Pharmacokinetics

43
Q

A specialized molecule, usually a protein, that carries a drug, transmitter, or other molecule across a membrane in which it is not permeable, eg, Na+/K+ATPase, serotonin reuptake transporter, etc

A

Transporter

44
Q

Drugs are chemicals that modify body functions. They may be ions, carbohydrates, lipids, or proteins. They vary in size from lithium (MW 7) to proteins (MW>50,000)

A

Nature of drugs

45
Q

Most drugs are administered at a site distant from their target tissue. To reach the target, they must permeate through both lipid and aqueous pathways. Movement of drugs occurs by means of aqueous diffusion, lipid diffusion, transport by special carriers, or by exocytosis and Endocytosis

A

Drug permeation

46
Q

Aqueous diffusion and lipid diffusion are predicted by Fick’s law and are directly proportional to the concentration gradient, area, and permeability coefficient and inversely proportional to the length or thickness of the diffusion path

A

Rate of diffusion

47
Q

Because the permeability coefficient of a weak base or weak acid varies with the pH according to the Henserson Hasselbalch equation, drugs may be trapped in a cellular compartment in which the pH is such as to reduce their solubility in the barriers surrounding the compartment

A

Drug tapping

48
Q

Drugs are usually administered by one of the following routes of administration: oral, buccal, sublingual, topical, transdermal, intravenous, subcutaneous, intramuscular, or rectal, or by inhalation

A

Routes of administration

49
Q

After absorption, drugs are distributed to different parts of the body depending on concentration gradient, blood flow, solubility, and binding in the tissue

A

Drug distribution

50
Q

Drugs are eliminated by reducing their concentration or amount in the body. This occurs when the drug is inactivated by metabolism or excreted from the body

A

Drug elimination

51
Q

The rate of elimination of drugs may be zero order (ie, constant regardless of concentration) or first order (ie, proportional to the concentration)

A

Elimination kinetics